The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PK-PD-efficacy modeling of brigimadlin in MDM2-amplified glioblastoma.
 
Rachael A. Vaubel
No Relationships to Disclose
 
Wenjuan Zhang
No Relationships to Disclose
 
Danielle M Burgenske
No Relationships to Disclose
 
Katie L Waller
No Relationships to Disclose
 
Paul A Decker
No Relationships to Disclose
 
Matt L Kosel
No Relationships to Disclose
 
Shiv K Gupta
No Relationships to Disclose
 
Zeng Hu
No Relationships to Disclose
 
Lauren L Ott
No Relationships to Disclose
 
Brett L Carlson
No Relationships to Disclose
 
Katrina K Bakken
No Relationships to Disclose
 
Surabhi Talele
No Relationships to Disclose
 
Ju-Hee Oh
No Relationships to Disclose
 
Jeanette Eckel-Passow
Research Funding - Exact Sciences
 
Patrizia Sini
Employment - Boehringer Ingelheim
 
Evanthia Galanis
Consulting or Advisory Role - Boston Scientific (Inst); Karyopharm Therapeutics (Inst); KIYATEC; SERVIER (Inst)
Research Funding - Denovo Biopharma (Inst); MedImmune (Inst); SERVIER (Inst)
 
William F Elmquist
No Relationships to Disclose
 
Jann Nagina Sarkaria
Consulting or Advisory Role - Aztek Biotech; Travecta Therapeutics
Research Funding - AbbVie; ABL Bio; AstraZeneca; Boehringer Ingelheim; Inhibrx; Karyopharm Therapeutics; Modifi Bio; Otomagnetics; Rain Therapeutics; Reglagene; SK Biopharmaceuticals; Sumitomo Dainippon Pharma Oncology; WUGEN, Inc.